{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:58:59Z","timestamp":1788307139732,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"Universit\u00e9 de Gen\u00e8ve","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune compromised children are threatened by a higher risk of infections; some of these are preventable by vaccination. Primary care physicians play a fundamental role in optimising vaccination status. In this narrative review, we present the evidence on vaccine safety and immunogenicity in immune compromised children and discuss in which conditions live-attenuated vaccines can possibly be used. Vaccination schedules differ in some of these conditions, including the use of vaccines with higher antigenic contents (e.g. high-dose hepatitis B vaccine), additional vaccine doses (e.g. 2-dose schedule meningococcal vaccine), more frequent booster doses (e.g. life-long pneumococcal vaccine booster), supplementary vaccines (e.g. meningococcal B vaccine) and use of vaccines beyond the age of usual recommendation (e.g. <jats:italic>Haemophilus influenza<\/jats:italic> type b vaccine after 5 years of age). Serological monitoring is a useful tool for customizing vaccination schedule in immune compromised children, confirming adequate vaccine response and documenting seroprotection (especially against measles and varicella). Finally, verification of vaccination status of all household members can prevent them being vector of transmission of an infection to the immune compromised children. <jats:italic>Conclusion<\/jats:italic>: Intensified information strategies are needed to improve trust, rectify perceived risks and improve vaccine acceptability; primary physicians can play a critical role in the latter.<jats:table-wrap><jats:table><jats:tbody>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is Known:<\/jats:bold>\u2022 <jats:italic>Physician\u2019s awareness is key to success, since it repeatedly correlates with higher vaccination rates<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                    <jats:tr>\n                      <jats:td colspan=\"2\"><jats:bold>What is New:<\/jats:bold>\u2022 <jats:italic>The vaccination status of immunocompromised children is rarely up-to-date<\/jats:italic>\u2022 <jats:italic>Knowing the latest vaccine recommendations is challenging, as they differ for each medical condition and change periodically<\/jats:italic>\u2022 <jats:italic>This review summarises the vaccine recommendations for children with compromised immune systems and highlights how paediatricians play a key role in coordinating their application<\/jats:italic><\/jats:td>\n                    <\/jats:tr>\n                  <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>","DOI":"10.1007\/s00431-021-03997-1","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:05:46Z","timestamp":1614902746000},"page":"2035-2047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Vaccination of immune compromised children\u2014an overview for physicians"],"prefix":"10.1007","volume":"180","author":[{"given":"Laure F.","family":"Pittet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9464-5704","authenticated-orcid":false,"given":"Klara M.","family":"Posfay-Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S1473-3099(16)00027-X","volume":"16","author":"M van Wijhe","year":"2016","unstructured":"van Wijhe M, McDonald SA, de Melker HE, Postma MJ, Wallinga J (2016) Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysis. Lancet Infect Dis 16:592\u2013598","journal-title":"Lancet Infect Dis"},{"key":"3997_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamapediatrics.2018.4954","volume":"173","author":"AG Feldman","year":"2019","unstructured":"Feldman AG, Beaty BL, Curtis D, Juarez-Colunga E, Kempe A (2019) Incidence of hospitalization for vaccine-preventable infections in children following solid organ transplant and associated morbidity, mortality, and costs. JAMA Pediatr 173:260\u2013268","journal-title":"JAMA Pediatr"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","volume":"267","author":"LJ Kaplan","year":"1992","unstructured":"Kaplan LJ, Daum RS, Smaron M, McCarthy CA (1992) Severe measles in immunocompromised patients. JAMA 267:1237\u20131241","journal-title":"JAMA"},{"key":"3997_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00134-019-05862-0","volume":"46","author":"LF Pittet","year":"2020","unstructured":"Pittet LF, Abbas M, Siegrist CA, Pittet D (2020) Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative review. Intensive Care Med 46:202\u2013214","journal-title":"Intensive Care Med"},{"key":"3997_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.15585\/mmwr.mm6745a2","volume":"67","author":"K VanderEnde","year":"2018","unstructured":"VanderEnde K, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS (2018) Global routine vaccination coverage - 2017. MMWR Morb Mortal Wkly Rep 67:1261\u20131264","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3997_CR6","first-page":"35","volume":"33","author":"MS Luna","year":"2020","unstructured":"Luna MS, Manzoni P, Paes B, Baraldi E, Cossey V, Kugelman A, Chawla R, Dotta A, Rodriguez Fernandez R, Resch B, Carbonell-Estrany X (2020) Expert consensus on palivizumab use for respiratory syncytial virus in developed countries. Paediatr Respir Rev 33:35\u201344","journal-title":"Paediatr Respir Rev"},{"key":"3997_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","volume":"134","author":"American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee","year":"2014","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134:415\u2013420","journal-title":"Pediatrics"},{"key":"3997_CR8","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1016\/j.jaci.2009.08.040","volume":"125","author":"J Chinen","year":"2010","unstructured":"Chinen J, Shearer WT (2010) Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol 125:S195\u2013S203","journal-title":"J Allergy Clin Immunol"},{"key":"3997_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41390-019-0507-4","volume":"87","author":"AG Feldman","year":"2020","unstructured":"Feldman AG, Curtis DJ, Moore SL, Kempe A (2020)Under-immunization of pediatric transplant recipients: a call to action for the pediatric community. Pediatr Res 87:277\u2013281","journal-title":"Pediatr Res"},{"key":"3997_CR10","doi-asserted-by":"crossref","unstructured":"Martinelli M, Giugliano FP, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, Navas-Lopez VM, Romano C, Sladek M, Veres G, Aloi M, Kucinskiene R, Miele E (2019) Vaccinations and immunization status in pediatric inflammatory bowel disease: a multicenter study from the Pediatric IBD Porto Group of the ESPGHAN. Inflamm Bowel Dis","DOI":"10.1093\/ibd\/izz264"},{"key":"3997_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1824-7288-36-28","volume":"36","author":"A Giannattasio","year":"2010","unstructured":"Giannattasio A, Squeglia V, Lo Vecchio A, Russo MT, Barbarino A, Carlomagno R, Guarino A (2010) Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Ital J Pediatr 36:28","journal-title":"Ital J Pediatr"},{"key":"3997_CR12","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1016\/j.vaccine.2016.11.015","volume":"34","author":"M Doherty","year":"2016","unstructured":"Doherty M, Schmidt-Ott R, Santos JI, Stanberry LR, Hofstetter AM, Rosenthal SL, Cunningham AL (2016) Vaccination of special populations: Protecting the vulnerable. Vaccine 34:6681\u20136690","journal-title":"Vaccine"},{"key":"3997_CR13","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1016\/j.vaccine.2017.09.031","volume":"35","author":"V Dipasquale","year":"2017","unstructured":"Dipasquale V, Romano C (2017) Vaccination strategies in pediatric inflammatory bowel disease. Vaccine 35:6070\u20136075","journal-title":"Vaccine"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2217\/IMT.15.74","volume":"7","author":"MM Eibl","year":"2015","unstructured":"Eibl MM, Wolf HM (2015) Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities. Immunotherapy 7:1273\u20131292","journal-title":"Immunotherapy"},{"key":"3997_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cgh.2015.09.042","volume":"14","author":"JD Feuerstein","year":"2016","unstructured":"Feuerstein JD, Castillo NE, Siddique SS, Lewandowski JJ, Geissler K, Martinez-Vazquez M, Thukral C, Leffler DA, Cheifetz AS (2016) Poor documentation of inflammatory bowel disease quality measures in academic, community, and private practice. Clin Gastroenterol Hepatol 14:421\u2013428.e422","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3997_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/1203475418811335","volume":"23","author":"KA Papp","year":"2019","unstructured":"Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J (2019) Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. J Cutan Med Surg 23:50\u201374","journal-title":"J Cutan Med Surg"},{"key":"3997_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S1473-3099(04)01106-5","volume":"4","author":"SK Obaro","year":"2004","unstructured":"Obaro SK, Pugatch D, Luzuriaga K (2004) Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 4:510\u2013518","journal-title":"Lancet Infect Dis"},{"key":"3997_CR18","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1016\/j.vaccine.2014.09.038","volume":"32","author":"S Esposito","year":"2014","unstructured":"Esposito S, Mastrolia MV, Prada E, Pietrasanta C, Principi N (2014) Vaccine administration in children with chronic kidney disease. Vaccine 32:6601\u20136606","journal-title":"Vaccine"},{"key":"3997_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.healun.2018.03.001","volume":"37","author":"WR Mulley","year":"2018","unstructured":"Mulley WR, Dendle C, Ling JEH, Knight SR (2018) Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant 37:844\u2013852","journal-title":"J Heart Lung Transplant"},{"key":"3997_CR20","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1542\/peds.2010-3706","volume":"127","author":"NP Klein","year":"2011","unstructured":"Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M (2011) Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics 127:e1139\u2013e1146","journal-title":"Pediatrics"},{"key":"3997_CR21","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1016\/j.vaccine.2012.10.012","volume":"30","author":"F Menni","year":"2012","unstructured":"Menni F, Chiarelli G, Sabatini C, Principi N, Esposito S (2012) Vaccination in children with inborn errors of metabolism. Vaccine 30:7161\u20137164","journal-title":"Vaccine"},{"key":"3997_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58:309\u2013318","journal-title":"Clin Infect Dis"},{"key":"3997_CR23","unstructured":"European Centre for Disease Prevention and Control. Vaccine schedules in all countries of the European Union 2020 [Available from: https:\/\/vaccine-schedule.ecdc.europa.eu\/. Accessed 18 April 2020]."},{"issue":"Suppl 5","key":"3997_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJ Drijkoningen","year":"2014","unstructured":"Drijkoningen JJ, Rohde GG (2014) Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect 20(Suppl 5):45\u201351","journal-title":"Clin Microbiol Infect"},{"key":"3997_CR25","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/ajg.2015.284","volume":"110","author":"B Kantso","year":"2015","unstructured":"Kantso B, Simonsen J, Hoffmann S, Valentiner-Branth P, Petersen AM, Jess T (2015) Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977-2013. Am J Gastroenterol 110:1582\u20131587","journal-title":"Am J Gastroenterol"},{"key":"3997_CR26","doi-asserted-by":"crossref","unstructured":"Lebel A, Kropach N, Ashkenazi-Hoffnung L, Huber-Yaron A, Davidovits M (2020) Infections in children with nephrotic syndrome: twenty years of experience. Clin Pediatr (Phila):9922820908583","DOI":"10.1177\/0009922820908583"},{"key":"3997_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","volume":"378","author":"A Di Sabatino","year":"2011","unstructured":"Di Sabatino A, Carsetti R, Corazza GR (2011) Post-splenectomy and hyposplenic states. Lancet 378:86\u201397","journal-title":"Lancet"},{"key":"3997_CR28","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1111\/j.1572-0241.2005.41939.x","volume":"100","author":"A Di Sabatino","year":"2005","unstructured":"Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, Carsetti R (2005) Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol 100:1788\u20131795","journal-title":"Am J Gastroenterol"},{"key":"3997_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.15585\/mmwr.mm6905a3","volume":"69","author":"CL Robinson","year":"2020","unstructured":"Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P (2020) Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2020. MMWR Morb Mortal Wkly Rep 69:130\u2013132","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3997_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/QCO.0b013e3283531b0f","volume":"25","author":"R Borrow","year":"2012","unstructured":"Borrow R, Heath PT, Siegrist CA (2012) Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis 25:292\u2013303","journal-title":"Curr Opin Infect Dis"},{"key":"3997_CR31","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/CCM.0000000000000545","volume":"42","author":"JR Ortiz","year":"2014","unstructured":"Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR (2014) The burden of influenza-associated critical illness hospitalizations. Crit Care Med 42:2325\u20132332","journal-title":"Crit Care Med"},{"key":"3997_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","volume":"18","author":"R Acevedo","year":"2019","unstructured":"Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, de Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, S\u00e1fadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, V\u00e1zquez JA, Zhu B (2019) The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines 18:15\u201330","journal-title":"Expert Rev Vaccines"},{"key":"3997_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/jcm4020260","volume":"4","author":"NM Reusser","year":"2015","unstructured":"Reusser NM, Downing C, Guidry J, Tyring SK (2015) HPV carcinomas in immunocompromised patients. J Clin Med 4:260\u2013281","journal-title":"J Clin Med"},{"key":"3997_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","volume":"4","author":"SM Garland","year":"2017","unstructured":"Garland SM, Brotherton JML, Moscicki AB, Kaufmann AM, Stanley M, Bhatla N, Sankaranarayanan R, de Sanjose S, Palefsky JM (2017) HPV vaccination of immunocompromised hosts. Papillomavirus Res 4:35\u201338","journal-title":"Papillomavirus Res"},{"key":"3997_CR35","doi-asserted-by":"crossref","unstructured":"Lai JJ, Lin C, Ho CL, Chen PH, Lee CH (2019)Alternative-dose versus standard-dose trivalent influenza vaccines for immunocompromised patients: A meta-analysis of randomised control trials. J Clin Med:8","DOI":"10.3390\/jcm8050590"},{"key":"3997_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.ajkd.2019.09.019","volume":"75","author":"D Miskulin","year":"2020","unstructured":"Miskulin D, Weiner DE, Manley HJ (2020)High-dose versus standard-dose influenza vaccine in hemodialysis patients. Am J Kidney Dis 75:456","journal-title":"Am J Kidney Dis"},{"key":"3997_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/14787210.2020.1713098","volume":"18","author":"M Mombelli","year":"2020","unstructured":"Mombelli M, Kampouri E, Manuel O (2020) Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Rev Anti Infect Ther 18:103\u2013112","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3997_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/pch\/pxx180","volume":"23","author":"DL Moore","year":"2018","unstructured":"Moore DL (2018) Immunization of the immunocompromised child: Key principles. Paediatr Child Health 23:203\u2013205","journal-title":"Paediatr Child Health"},{"key":"3997_CR39","doi-asserted-by":"crossref","unstructured":"Top KA, Vaudry W, Morris SK, Pham-Huy A, Pernica JM, Tapiero B, Gantt S, Price VE, Rassekh SR, Sung L, McConnell A, Rubin E, Chawla R, Halperin SA (2020) Waning vaccine immunity and vaccination responses in children treated for acute lymphoblastic leukemia: A Canadian Immunization Research Network Study. Clin Infect Dis","DOI":"10.1093\/cid\/ciaa163"},{"key":"3997_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1542\/peds.90.2.216","volume":"90","author":"R Lynfield","year":"1992","unstructured":"Lynfield R, Herrin JT, Rubin RH (1992) Varicella in pediatric renal transplant recipients. Pediatrics 90:216\u2013220","journal-title":"Pediatrics"},{"key":"3997_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0022-3476(81)80527-6","volume":"98","author":"CM Feldhoff","year":"1981","unstructured":"Feldhoff CM, Balfour HH Jr, Simmons RL, Najarian JS, Mauer SM (1981) Varicella in children with renal transplants. J Pediatr 98:25\u201331","journal-title":"J Pediatr"},{"key":"3997_CR42","doi-asserted-by":"publisher","first-page":"101016","DOI":"10.1016\/j.pmedr.2019.101016","volume":"16","author":"AM Lachiewicz","year":"2019","unstructured":"Lachiewicz AM, Srinivas ML (2019)Varicella-zoster virus post-exposure management and prophylaxis: A review. Prev Med Rep 16:101016","journal-title":"Prev Med Rep"},{"key":"3997_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jaip.2016.09.012","volume":"4","author":"A Sobh","year":"2016","unstructured":"Sobh A, Bonilla FA (2016) Vaccination in primary immunodeficiency disorders. J Allergy Clin Immunol Pract 4:1066\u20131075","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3997_CR44","doi-asserted-by":"crossref","unstructured":"Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, Azizi G, Rafiemanesh H, Hassanpour G, Rezaei N, Abolhassani H, Aghamohammadi A (2020) Primary immunodeficiency diseases and Bacillus Calmette-Guerin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract","DOI":"10.1016\/j.jaip.2020.01.038"},{"key":"3997_CR45","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Recommended immunization schedule for adults and adolescents with HIV infection. [updated 13 Sept 2017, available from: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed 17 May 2020]."},{"issue":"Suppl 1","key":"3997_CR46","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1093\/infdis\/jir071","volume":"204","author":"P Scott","year":"2011","unstructured":"Scott P, Moss WJ, Gilani Z, Low N (2011) Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis 204(Suppl 1):S164\u2013S178","journal-title":"J Infect Dis"},{"key":"3997_CR47","doi-asserted-by":"crossref","unstructured":"Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger-Isakov L, Dipchand AI, Hebert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon M, Tapiero B, Verma A, Walter JE, Allen UD (2019) Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018. Pediatr Transplant:e13571","DOI":"10.1111\/petr.13571"},{"key":"3997_CR48","unstructured":"Patel S, Heath P, Skinner R. Vaccinations for paediatric patients treated with standard-dose chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients 2017 [updated Sept 2017, available from: https:\/\/www.cclg.org.uk\/write\/MediaUploads\/Member%20area\/Treatment%20guidelines\/Vaccinations_for_Children_treated_with_Standard-dose_Chemotherapy_and_HSCT_Recipients-Sept_2014-FINAL_CCLG.pdf. Accessed 8 Feb 2020]"},{"key":"3997_CR49","doi-asserted-by":"crossref","unstructured":"Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, Small T, Center for International B, Marrow Transplant R, National Marrow Donor P, European B, Marrow Transplant G, American Society of B, Marrow T, Canadian B, Marrow Transplant G, Infectious Disease Society of A, Society for Healthcare Epidemiology of A, Association of Medical M, Infectious Diseases C, Centers for Disease C, Prevention (2009) Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 44:521-526","DOI":"10.1038\/bmt.2009.263"},{"key":"3997_CR50","doi-asserted-by":"crossref","unstructured":"Kamei K, Miyairi I, Ishikura K, Ogura M, Shoji K, Funaki T, Ito R, Arai K, Abe J, Kawai T, Onodera M, Ito S (2018) Prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents. J Pediatr 196:217-222.e211","DOI":"10.1016\/j.jpeds.2017.12.061"},{"issue":"Suppl","key":"3997_CR51","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jinf.2016.04.017","volume":"72","author":"MV Pinto","year":"2016","unstructured":"Pinto MV, Bihari S, Snape MD (2016) Immunisation of the immunocompromised child. J Infect 72(Suppl):S13\u2013S22","journal-title":"J Infect"},{"key":"3997_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","volume":"141","author":"FA Bonilla","year":"2018","unstructured":"Bonilla FA (2018) Update: Vaccines in primary immunodeficiency. J Allergy Clin Immunol 141:474\u2013481","journal-title":"J Allergy Clin Immunol"},{"key":"3997_CR53","doi-asserted-by":"crossref","unstructured":"Medical Advisory Committee of the Immune Deficiency Foundation, Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, et al. (2014) Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 133:961-966","DOI":"10.1016\/j.jaci.2013.11.043"},{"key":"3997_CR54","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1016\/j.vaccine.2018.01.061","volume":"36","author":"B Martire","year":"2018","unstructured":"Martire B, Azzari C, Badolato R, Canessa C, Cirillo E, Gallo V, Graziani S, Lorenzini T, Milito C, Panza R, Moschese V, with Italian Network for Primary Immunodeficiencies (2018) Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET). Vaccine 36:3541\u20133554","journal-title":"Vaccine"},{"key":"3997_CR55","doi-asserted-by":"publisher","first-page":"707691","DOI":"10.1155\/2014\/707691","volume":"2014","author":"S Cesaro","year":"2014","unstructured":"Cesaro S, Giacchino M, Fioredda F, Barone A, Battisti L, Bezzio S, Frenos S, De Santis R, Livadiotti S, Marinello S, Zanazzo AG, Caselli D (2014) Guidelines on vaccinations in paediatric haematology and oncology patients. Biomed Res Int 2014:707691","journal-title":"Biomed Res Int"},{"issue":"333-336","key":"3997_CR56","first-page":"e331","volume":"13","author":"EN Menson","year":"2012","unstructured":"Menson EN, Mellado MJ, Bamford A, Castelli G, Duiculescu D, Marczynska M, Navarro M, Scherpbier HJ, Heath PT (2012) Guidance on vaccination of HIV-infected children in Europe. HIV Med 13(333-336):e331\u2013e314","journal-title":"HIV Med"},{"key":"3997_CR57","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","volume":"29","author":"E Benamu","year":"2016","unstructured":"Benamu E, Montoya JG (2016) Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis. Curr Opin Infect Dis 29:319\u2013329","journal-title":"Curr Opin Infect Dis"},{"key":"3997_CR58","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1080\/21645515.2015.1074358","volume":"11","author":"A Gagneur","year":"2015","unstructured":"Gagneur A, Pinquier D, Quach C (2015) Immunization of preterm infants. Hum Vaccin Immunother 11:2556\u20132563","journal-title":"Hum Vaccin Immunother"},{"key":"3997_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jped.2019.09.004","volume":"96","author":"LE Calliari","year":"2020","unstructured":"Calliari LE, Almeida FJ, Noronha RM (2020) Infections in children with diabetes. J Pediatr (Rio J) 96:39\u201346","journal-title":"J Pediatr (Rio J)"},{"issue":"Suppl 1","key":"3997_CR60","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1016\/j.jcjd.2017.10.016","volume":"42","author":"N Husein","year":"2018","unstructured":"Husein N, Chetty A (2018) Influenza, pneumococcal, hepatitis b and herpes zoster vaccinations. Can J Diabetes 42(Suppl 1):S142\u2013s144","journal-title":"Can J Diabetes"},{"key":"3997_CR61","unstructured":"World Federation of Hemophilia. Guidelines for the Management of Hemophilia 2012 [Available from: https:\/\/elearning.wfh.org\/resource\/treatment-guidelines\/. Accessed 18 April 2020]."},{"key":"3997_CR62","doi-asserted-by":"crossref","unstructured":"Gibson D, Mehler PS (2019) Anorexia nervosa and the immune system-a narrative review. J Clin Med 8","DOI":"10.3390\/jcm8111915"},{"key":"3997_CR63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML (2016) Impact of obesity and metabolic syndrome on immunity. Adv Nutr 7:66\u201375","journal-title":"Adv Nutr"},{"key":"3997_CR64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1089\/chi.2016.0176","volume":"13","author":"R Kelishadi","year":"2017","unstructured":"Kelishadi R, Roufarshbaf M, Soheili S, Payghambarzadeh F, Masjedi M (2017) Association of childhood obesity and the immune system: a systematic review of reviews. Child Obes 13:332\u2013346","journal-title":"Child Obes"},{"key":"3997_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10096-015-2558-8","volume":"35","author":"C Tagliabue","year":"2016","unstructured":"Tagliabue C, Principi N, Giavoli C, Esposito S (2016) Obesity: impact of infections and response to vaccines. Eur J Clin Microbiol Infect Dis 35:325\u2013331","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3997_CR66","doi-asserted-by":"crossref","unstructured":"Snyder J, Butzner JD, DeFelice AR, Fasano A, Guandalini S, Liu E, Newton KP (2016)Evidence-informed expert recommendations for the management of celiac disease in children. Pediatrics:138","DOI":"10.1542\/peds.2015-3147"},{"key":"3997_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjmed.2017.07.021","volume":"131","author":"M Simons","year":"2018","unstructured":"Simons M, Scott-Sheldon LAJ, Risech-Neyman Y, Moss SF, Ludvigsson JF, Green PHR (2018) Celiac disease and increased risk of pneumococcal infection: a systematic review and meta-analysis. Am J Med 131:83\u201389","journal-title":"Am J Med"},{"key":"3997_CR68","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1080\/21645515.2018.1460986","volume":"14","author":"M Dinleyici","year":"2018","unstructured":"Dinleyici M, Carman KB, Kilic O, Laciner Gurlevik S, Yarar C, Dinleyici EC (2018) The immunization status of children with chronic neurological disease and serological assessment of vaccine-preventable diseases. Hum Vaccin Immunother 14:1970\u20131976","journal-title":"Hum Vaccin Immunother"},{"key":"3997_CR69","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1610-0387.2007.06488.x","volume":"5","author":"AK Kienast","year":"2007","unstructured":"Kienast AK, Kreth HW, Hoger PH (2007) Varicella vaccination in children with atopic eczema. J Dtsch Dermatol Ges 5:875\u2013880","journal-title":"J Dtsch Dermatol Ges"},{"key":"3997_CR70","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin SA (2010) Correlates of protection induced by vaccination. Clin Vaccine Immunol 17:1055\u20131065","journal-title":"Clin Vaccine Immunol"},{"key":"3997_CR71","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1086\/589862","volume":"47","author":"SA Plotkin","year":"2008","unstructured":"Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47:401\u2013409","journal-title":"Clin Infect Dis"},{"key":"3997_CR72","unstructured":"Plotkin SA, Orenstein WA, Offit PA (2012) Vaccines.6th edition edn. Elsevier, Philadelphia, PA"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-03997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-03997-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-03997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T22:05:38Z","timestamp":1675029938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-03997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-03997-1","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}